Security Snapshot

LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share (LIXT) Institutional Ownership

CUSIP: 539319301

13F Institutional Holders and Ownership History from Q2 2023 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

14

Shares (Excl. Options)

732,501

Price

$3.07

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
LIXT on Nasdaq
Shares outstanding
2,666,933
Price per share
$3.50
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
732,501
Total reported value
$2,247,945
% of total 13F portfolios
0%
Share change
-32,451
Value change
-$172,595
Number of holders
14
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • LIXT - LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share is tracked under CUSIP 539319301.
  • 14 institutions reported positions in Q1 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 17 to 14 between Q4 2025 and Q1 2026.
  • Reported value moved from $2,968,653 to $2,247,945.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 14 institutions filings for Q1 2026.

Open SEC Evidence

Security key

539319301

Latest holder period

Q1 2026

13F holders

14

13D/G owners

2

CIK / CUSIP context first

Open Q1 2026 holders LIXT full holder history LIXTE BIOTECHNOLOGY HOLDINGS, INC. SEC filings LIXTE BIOTECHNOLOGY HOLDINGS, INC. company facts LIXTE BIOTECHNOLOGY HOLDINGS, INC. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Significant Owners of LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share (LIXT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
INTRACOASTAL CAPITAL, LLC 5% $181,780 138,763 Mitchell P. Kopin 11 Feb 2025
Orca Capital AG 4.5% -45% $157,216 -$127,568 120,012 -45% Orca Capital AG 14 Feb 2025

As of 31 Mar 2026, 14 institutional investors reported holding 732,501 shares of LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share (LIXT). This represents 27% of the company’s total 2,666,933 outstanding shares.

Top 20 Institutional Shareholders

The largest institutional shareholders of LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share (LIXT) together control 27% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
SCOTIA CAPITAL INC. 11% 283,162 +9.5% 0% $869,307
RENAISSANCE TECHNOLOGIES LLC 3.5% 93,000 -13% 0% $285,510
Federation des caisses Desjardins du Quebec 2.4% 64,487 -31% 0% $197,975
GEODE CAPITAL MANAGEMENT, LLC 2.2% 58,852 +13% 0% $180,675
CITADEL ADVISORS LLC 2.1% 56,557 +301% 0% $173,630
VANGUARD CAPITAL MANAGEMENT LLC 1.9% 49,479 0% 0% $151,901
VANGUARD FIDUCIARY TRUST CO 1.3% 35,034 0% 0% $107,554
Ethos Financial Group, LLC 0.93% 24,808 0% 0.01% $76,161
XTX Topco Ltd 0.88% 23,446 +61% 0% $71,979
STATE STREET CORP 0.65% 17,396 0% 0% $53,406
Atlas Legacy Advisors, LLC 0.52% 13,771 0% 0.01% $42,277
HRT FINANCIAL LP 0.43% 11,346 0% $34,000
Tower Research Capital LLC (TRC) 0.04% 973 0% $2,987
SBI Securities Co., Ltd. 0.01% 190 0% 0% $583
TWO SIGMA INVESTMENTS, LP 0% 0 -100% $0
CITIGROUP INC 0% 0 -100% $0
BANK OF AMERICA CORP /DE/ 0% 0 -100% $0
AXXCESS WEALTH MANAGEMENT, LLC 0% 0 -100% $0
UBS Group AG 0% 0 -100% $0
DRW Securities, LLC 0% 0 -100% $0

Institutional Holders of LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share (LIXT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 732,501 $2,247,945 -$172,595 $3.07 14
2025 Q4 755,383 $2,968,653 +$1,130,402 $3.93 17
2025 Q3 438,741 $2,207,346 +$1,384,461 $5.03 16
2025 Q2 163,636 $148,054 -$163,058 $0.90 10
2025 Q1 300,011 $384,657 -$81,359 $1.21 9
2024 Q4 297,557 $607,533 +$138,617 $2.03 10
2024 Q3 215,532 $409,125 +$72,342 $1.87 7
2024 Q2 178,383 $424,174 +$88,625 $2.37 6
2024 Q1 138,296 $467,369 +$81,413 $3.38 6
2023 Q4 114,289 $267,989 +$177,089 $2.34 6
2023 Q3 37,983 $92,809 +$15,777 $2.45 6
2023 Q2 17,340 $101,452 +$101,452 $5.88 5
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .